Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Markets & Finance

Lehmans Cuts CVS to Buy from Strong Buy

Lehman Brothers cut its rating on shares of CVS (CVS) to buy from strong buy.

Analyst Meredith Adler said the outlook for next 6-12 months is cloudy. She notes the weak economy, and the increasingly competitive retail environment. She adds that gross margins have been pressured in both the pharmacy and front end businesses. She also notes that Rite Aid has been the most aggressive player in the retail drugstore sector. The analyst says Rite Aid can afford to be more promotional -- offering lower prices -- than CVS for some time.

The analyst also says that CVS won't cut expenses meaningfully as it tries to drive growth, which adds uncertainty to EPS estimates. Adler sees 2001 EPS of $1.81 and 2002 EPS of $2.00. She also cut her price target for the stock to $35 from $37.

blog comments powered by Disqus